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Abstract
Background: Demonstrating an association between physical malformation and schizophrenia
could be considered supportive of a neurodevelopmental origin of schizophrenia and may offer
insights into a critical period for the development of this illness. The aim of our study was to
investigate whether differences in the presence of minor physical anomalies could be demonstrated
between schizophrenia sufferers and normal controls in a Xhosa population with a view to
identifying a means of subtyping schizophrenia for use in future genetic studies.
Methods: Sixty-three subjects with schizophrenia (21 sibling pairs, 1 sibship of four and a group
of probands with an affected non-participating sibling (n = 17)), 81 normal controls (37 singletons
and 22 sibling pairs) of Xhosa ethnicity were recruited. Each participant was then examined for
minor physical anomalies using the Modified Waldrop scale. The relationship between each of the
morphological features and the presence of an affected sib was examined using the Chi-squared
test, followed by an intra-pair concordance analysis in the sibling pairs.
Results: Gap between first and second toes was significantly more common in the affected sib pair
group when compared to the non-affected sib pair group (p = 0.019) and non-affected singleton
control group (p = 0.013). Concordance analysis also revealed increased concordance for this item
in the affected sib pair group.
Conclusion: These findings offer an intriguing possibility that in the Xhosa population, affected sib
pair status may be linked to a neurodevelopmental insult during a specific period of the fetal
developmental.
Background
Schizophrenia seems to be a heterogeneous illness result-
ing from a complex interplay between genetic and envi-
ronmental risk factors. It is currently thought that genetic
factors may account for as much as 80% of the risk for
developing schizophrenia and that first degree relatives of
persons with schizophrenia are at higher risk of develop-
ing schizophrenia than the general population [1,2]. The
risk varies according to the closeness of the relationship
from approximately 8% for a non- twin sibling, to 46%
for the child of two schizophrenic parents and 48% for the
monozygotic twin of a schizophrenia patient [3].
Published: 27 October 2006
BMC Psychiatry 2006, 6:47 doi:10.1186/1471-244X-6-47
Received: 20 June 2006
Accepted: 27 October 2006
This article is available from: http://www.biomedcentral.com/1471-244X/6/47
© 2006 Koen et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Psychiatry 2006, 6:47 http://www.biomedcentral.com/1471-244X/6/47
Page 2 of 5
(page number not for citation purposes)
Despite the apparent genetic contribution, the specific
mechanism or gene has yet to be found. Indeed, models
predict that schizophrenia probably has a multigenetic
basis with varying contributions to the risk profile. It is
thus not surprising that linkage and association studies
have mapped genetic loci and tested candidate genes that
appear to confer susceptibility to several chromosomal
areas including 1q21-22, 1q32-34, 6p24, 8p21, 10p14,
13q32, 18p11and 22q11-13 [4,2].
In the search for the susceptibility genes it has became
apparent that one possible method would be to identify a
specific subgroup of schizophrenia and then attempt to
locate the underlying mechanism for schizophrenia. Sev-
eral approaches have been advocated for the subtyping of
schizophrenia and these include demographic variables,
clinical symptoms, physical characteristics and early ver-
sus late developmental insults [2]. Early developmental
insults (genetic or environmental) are of particular inter-
est in terms of the neurodevelopmental model of schizo-
phrenia since anthropometric studies have documented
multiple anomalies of the craniofacial region in schizo-
phrenic patients [2].
An animal model of non-human primates showed that
irradiation during thalamogenesis led to craniofacial
abnormalities similar to those reported in schizophrenic
subjects [5]. This may not be surprising since the brain
and face develop from the same embryonic primordia.
Furthermore, retinoic acid plays an important role during
this developmental phase and retinoic acid dysregulation
has been suggested as a contributing factor to the develop-
ment of schizophrenia.
The aim of our study was therefore to investigate whether
differences in the presence of minor physical anomalies
could be demonstrated between schizophrenia sufferers
and normal controls in a Xhosa population with a view to
identifying a means of subtyping schizophrenia (based on
the presence or absence of early developmental abnormal-
ities) for future genetic studies. To improve the chances of
a significant finding sib pairs were included, as the pres-
ence of an affected sibling not only carries an increased
risk for schizophrenia but it is likely that concordant fac-
tors within a sib pair will represent shared familial or envi-
ronmental factors.
Methods
Subjects
144 Xhosa subjects were recruited from in and outpatient
services and general communities in the Western and
Eastern Cape provinces of South Africa as part of an ongo-
ing genetic study. Suitable candidates were identified by
local mental health workers from all clinics within the
geographic areas where Xhosa people lived. If the individ-
uals were willing to voluntarily participate they were inter-
viewed for suitability by the research team after written
informed consent was given. Each participant had to be of
Xhosa origin, suffer from schizophrenia (DSM-IV; if part
of affected group) and voluntarily agree to participation.
The Xhosa are an African population that form part of the
Nguni language group. The relevant ethics body of the
University of Stellenbosch approved this study, based on
the principles of the Declaration of Helsinki.
Assessment tools
Participants were assessed with the Diagnostic Interview
for Genetic Studies (DIGS; version 2.0) [6] and the Modi-
fied Waldrop Scale [7]. The DIGS is an assessment tool
structured to elicit psychotic, mood and comorbid disor-
ders. The Modified Waldrop Scale (MWS) assesses vari-
ance in morphological features and includes the eyes,
ears, oral cavity, hands and feet. Each individual was vid-
eotaped (still images available where applicable) in a
standardized manner at standard camera-patient distance
with a frontal and profile view of the head, palmar and
dorsal views of the hands (fingers spread and unspread)
and dorsal views of the feet with toes slightly spread. An
experienced clinical geneticist (GDJ) evaluated each
image blind to the clinical psychiatric symptom status and
rated it according to the anchor points on the MWS. Only
items of the MWS that were adjudged to lend themselves
to reliable assessment on a still image were included.
Unclear or indeterminate ratings were noted as unsure
and excluded in the statistical analysis.
Statistical analysis
The participants were divided into four groups, that of (a)
group 1 – affected sib pairs (23 sib pairs [sibship of 4 pro-
vided 2 sib pairs]); (b) group 2 – 17 subjects with an
affected non-participating sib; (c) group 3 – healthy indi-
viduals with no affected sib (n = 37) and (d) group 4 –
unaffected sib pairs (22 sib pairs). The four groups were
compared in terms of demographic variables. An overall
test was done to see if the four groups were different with
relation to the proportion of subjects with an abnormal
feature and if significant (or marginally significant at the
5% level). Group 1 (schizophrenia sib group) was com-
pared to each of the other three groups. Allowance was
made for the correlation between the sib pairs in the anal-
yses. A multivariate – and concordance analysis was sub-
sequently performed.
Results
One hundred and forty four Xhosa subjects (109 males
and 35 females) were recruited. The age at interview was
36.74 years (SD 10.24; range 21–66 years) and the age of
onset 22.64 years (SD 5.35; range 14–39) for the affected
individuals. The mean years of schooling was 7.29 (SDBMC Psychiatry 2006, 6:47 http://www.biomedcentral.com/1471-244X/6/47
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3.35) and 80% of the affected individuals were in receipt
of a disability allowance.
The group was stratified into a sib pair group (n = 46 or 21
sib pairs and 1 sibship of four), a group of probands with
an affected non-participating sib (n = 17), a singleton con-
trol group (n = 37) and an unaffected sib pair control
group (22 sib pairs). The non-participating sib did com-
plete a full DIGS assessment as part of an ongoing genetic
study.
The sib pair group constituted 15 male-male sib pairs, 7
male-female pairs and 1 female-female pair. This included
the larger sibship that was divided into two sib pairs on
the basis of 1st and 2nd assessed (male-male pair) and 3rd
and 4th assessed (male-female pair). The singleton group
had 9 females and the group of probands with an affected
non-participating sib 1 female in the group. The unaf-
fected sib pair group consisted of 11 male-male sib pairs,
6 male-female pairs and 5 female-female pairs.
The univariate model (table 1) indicated significant differ-
ences between the affected and the non-affected sib pair
groups (group 1 + 4) in terms of the presence of adherent
earlobes (p = 0.0004), palatal abnormalities (p = 0.0001)
and gap between first and second toes (p = 0.019). Signif-
icant differences were also detected between affected sib
pairs and non-affected singleton controls (group 1 + 3) in
terms of the presence of asymmetrical ears (p = 0.011) and
gap between first and second toes (p = 0.013). The con-
cordance analysis (between affected and non-affected sib
pair groups) revealed significance for only one item that
was also more prevalent in the schizophrenia sib pair
group – gap between first and second toes (p = 0.021)
(Table 2).
The multivariate analysis revealed that gender was a sig-
nificant variable in the model for asymmetrical ears
(males, p = 0.008), syndactaly (females, p = 0.0004) and
gap between first and second toes (males, p = 0.009), but
including gender in the model did not change the results
for the morphological features, i.e. gender did not con-
found the relationship of the groups with the morpholog-
ical features.
Discussion and conclusion
This is the first study to report on the morphological fea-
tures as measured by the Modified Waldrop scale, in an
Table 1: Affected sib pairs compared to other groups: Univariate model
Variable % Abnormal Chi-square P
Group* 1234
N 46 17 37 44
Epicantus 10.9 23.5 24.3 31.0 5.65 0.130
Low set ears 35.6 29.4 30.6 17.9 2.85 0.415
Adherent earlobes 26.2 31.3 33.3 65.1 13.94 0.003
sSibs vs grp 2 0.37 0.543
sSibs vs grp 3 0.86 0.353
sSibs vs grp 4 12.59 0.0004
Malformed ears 9 . 10 . 08 . 12 . 3 - -
Palatal abnormalities 48.6 41.7 36.0 96.3 19.13 0.0003
sSibs vs grp 2 0.10 0.750
sSibs vs grp 3 0.69 0.407
sSibs vs grp 4 15.29 0.0001
Tongue abnormalities 10.3 11.1 17.9 19.5 1.71 0.635
5thfinger variations 17.8 25.0 21.6 18.6 0.35 0.950
Transverse palmar crease 2 . 20 . 02 . 87 . 0 - -
Third toe abnormalities 0 . 00 . 00 . 00 . 0 - -
Syndactalia 19.6 6.3 25.0 18.6 3.86 0.277
Asymmetrical ears 9.1 17.7 32.4 2.3 12.68 0.005
sSibs vs grp 2 0.64 0.422
sSibs vs grp 3 6.51 0.011
sSibs vs grp 4 2.25 0.133
Gap between toes 31.1 20.0 5.6 7.0 7.43 0.059
sSibs vs grp 2 0.55 0.460
sSibs vs grp 3 6.16 0.013
sSibs vs grp 4 5.52 0.019
*Group 1 sib pairs with schizophrenia (sSibs)
Group 2 probands with an affected non-participating sib
Group 3 singleton controls, unaffected
Group 4 sib pairs, unaffectedBMC Psychiatry 2006, 6:47 http://www.biomedcentral.com/1471-244X/6/47
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African Xhosa schizophrenia sib pair population. Minor
physical anomalies were noted in all of the items meas-
ured by the Modified Waldrop Scale. The most striking
finding is that of significantly more subjects with a gap
between the toes in the affected sib pair group and the
affected sib with non-participating sib group. Although
other significant differences were detected, only gap
between toes shows a consistent pattern as would be
expected if a morphological abnormality contributed to
the affected status. Given the increased morbid risk for a
sib of a schizophrenic this finding may suggest that this
anomaly represents a developmental period of specific
importance in familial cases of schizophrenia. This find-
ing differs from that of Gourion et al. [8] who reported a
higher rate of low set ears (OR = 11.9), cleft palate (OR =
8.5), curved 5th finger (OR = 3.6) and syndactaly (OR =
3.6) in schizophrenia patients compared to controls.
However, it still supports the possible role of brain devel-
opmental processes in the risk for schizophrenia and the
differences may be linked to population specific risk fac-
tors for schizophrenia.
The interpretation of the data is subject to the following
methodological problems: the sample size is small and
type 2 errors could have occurred. It could be that the
unaffected siblings from the singleton group have not yet
passed through the vulnerability phase for schizophrenia
and this could have an influence on the group distribu-
tions. It would be of value to also incorporate a control
group in as far as some of the items that were either con-
cordant or significantly different between the groups
might represent a less familial risk period for the develop-
ment of schizophrenia.
Nevertheless, the development of the distal extremities
takes place between day 50 and 70 of gestation, in the
same time frame as the development of the thalamus.
Indeed, Andreasen [9] has proposed that schizophrenia is
a neurodevelopmental illness which arises because of a
defect in prefrontal-thalamic-cerebellar circuitry. The tha-
lamus is a key relay nucleus that modulates both motor
and cognitive coordination. Deficits have been described
in both these modalities [10-12].
Table 2: Modified Waldrop items: concordance findings for affected and non-affected sib pairs
STATISTICS
ITEM GROUP CONCORDANT FOR 
ABSENCE OF 
DYSMORPHOLOGY
DISCONCORDANT CONCORDANT FOR 
PRESENCE OF 
DYSMORPHOLOGY
CHI 
SQUARE
p
Low set ears sSibs 11 50.0 7 31.8 4 18.2 2.09 0.35
unafSibs 13 72.2 3 16.7 2 11.1
Epicanthus sSibs 19 82.6 3 13.0 1 4.4 3.94 0.14
unafSibs 11 55.0 7 35.0 2 4.7
5th finger sSibs 17 77.3 2 9.1 3 13.6 7.37 0.025
unafSibs 14 66.7 7 33.3 0 0.0
Adherent ear 
lobe
sSibs 11 57.9 5 26.3 3 15.8 11.42 0.003
unafSibs 2 9.5 11 52.4 8 38.1
Malformed 
ears
sSibs 17 80.9 4 19.1 0 0.0 2.17 0.14
unafSibs 20 95.2 1 4.8 0 0.0
Asymmetrical 
ears
sSibs 17 80.9 4 19.1 0 0.0 2.17 0.14
unafSibs 20 95.2 1 4.8 0 0.0
abnormalities sSibs 6 85.7 1 14.3 0 0.0 1.45 0.25
unafSibs 12 63.2 7 36.8 0 0.0
Gap between 
1st and 2nd toe
sSibs 12 54.6 6 27.3 4 18.2 7.75 0.021
unafSibs 18 85.7 3 14.3 0 0.0
Palatal 
abnormalities
sSibs 4 25.0 8 50.0 4 25.0 16.62 0.0002
unafSibs 0 0.0 0 0.0 9 100
Syndactalia sSibs 15 65.2 7 30.4 1 4.4 0.021 0.99
unafSibs 14 66.7 6 28.6 1 4.8
Transverse 
palmar crease
sSibs 19 95.0 1 5.0 0 0.0 2.17 0.14
unafSibs 20 91.4 2 9.6 0 0.0
sSibs = group 1 = sib pairs with schizophrenia
unafSibs = group 4 = sib pairs, unaffectedPublish with BioMed Central    and   every 
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There has also been some structural evidence for thalamic
abnormality in schizophrenia. Several neuropathological
studies, including the study of Pakkenburg [13] have
shown decreased neuronal density and reduced volume of
the medial dorsal nucleus of the thalamus in the absence
of gliosis, again suggesting a neurodevelopmental rather
than neurodegenerative process. Four magnetic resonance
studies [9] showed reduced thalamic size and two PET
studies [14,15] showed abnormal thalamic activity in
patients suffering from schizophrenia. Thus, apart from
the possible link between our morphological findings and
thalamic development, there also seems to be a clear link
between the thalamus and the pathophysiology of schiz-
ophrenia.
These findings offer an intriguing possibility that in the
Xhosa population, affected sib pair status may be linked
to a neurodevelopmental insult during a specific period of
the fetal developmental. Follow-up studies in an inde-
pendent sample will investigate these and other morpho-
logical abnormalities that could narrow the risk period
and may offer some insights into the susceptibility of
schizophrenia. Furthermore, in the light of the previously
reported finding that the core symptoms of schizophrenia
in the Xhosa population is similar to that found in other
ethnic populations [16] it would be very interesting to
compare our specific minor physical anomalies presence
findings with those previously reported in Caucasian pop-
ulations.
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